Bayer is backing up its move into the cell therapy category led by subsidiary BlueRock Therapeutics with a $250 million investment in a new manufacturing facility in Berkeley, California.

Bayer UK launches new CanesMeno Educational Hub and product range to transform menopause support: Leverkusen Friday, January ...

Jeanne Kehren, head of digital and commercial innovation at Bayer, said: “Building new digital business models is a key element of our business strategy with the ambition to actively shape the ...